"Hepatitis is a silent killer. When you get infected, you often
don't have severe symptoms that make you go to the doctor," said Dr.
John Ward, director of the Coalition for Global Hepatitis
Elimination at the Task Force for Global Health in Decatur, Georgia.
"Hepatitis B and C can become chronic infections and cause liver
damage over time, which can lead to liver cancer," Ward, who is also
a senior scientist at the CDC, said in a phone interview. "It's
important for people to be tested so infections can be caught early
before they become a problem."
Hepatitis B and C are the most common types of viral hepatitis in
the U.S., according to the CDC's announcement, published in the
agency's Morbidity and Mortality Weekly Report. In 2016, about
862,000 people were living with hepatitis B and 2.4 million were
living with hepatitis C, despite the availability of a vaccine and
treatment for hepatitis B and a cure for hepatitis C.
New cases of hepatitis C tripled during 2010-2016, mostly among
young adults, largely attributed to surges in the opioid epidemic
and injection-drug use. It can also be spread through exposure to
blood in healthcare settings, particularly through blood
transfusions given before 1992, and occasionally through sexual
contact.
"All Baby Boomers should be tested since they're at a high risk for
unscreened blood before 1992," Ward said. "But the new threat has
also been for young people involved in the opioid crisis with
injection use."
The other form of the disease, caused by the hepatitis A virus,
doesn't have a treatment but is preventable through vaccination.
Several states have had outbreaks since 2016 with a large number of
cases caused by person-to-person transmission, primarily among those
who use drugs or experience homelessness, the announcement notes.
[to top of second column] |
To increase awareness, the CDC is encouraging the public and doctors
to "Learn the ABCs" of viral hepatitis, and offering resources and
links to find a testing facility nearby (here: https://bit.ly/2osb65W).
If unsure about what to do next, individuals can also take a
five-minute online assessment (here: https://bit.ly/2imA3Ih) to
receive a personalized report on hepatitis testing and vaccine
recommendations. The assessment is anonymous and asks questions
about a history of blood disease, liver disease, sexually
transmitted infections, HIV/AIDs, injection drug use, blood
transfusions and overseas travel.
Chronic hepatitis is a leading cause of liver cancer and cirrhosis,
with more than 60 percent of liver cancer cases related to hepatitis
B or C, the CDC resources highlight.
"Chronic HBV and HCV infections already kill as many people
worldwide as HIV, malaria and tuberculosis," said Dr. David Thomas,
director of the division of infectious diseases at Johns Hopkins
Medicine in Baltimore, Maryland, who isn't involved in the CDC
awareness campaign.
By 2040, hepatitis deaths are expected to exceed the combined
mortality of HIV, malaria and tuberculosis because there are global
programs to eliminate those diseases, he added.
"Get tested. The tests are accurate and can identify a condition
that is treatable," he told Reuters Health by email. "Being cured
can save your life and the lives of those around you."
SOURCE: https://bit.ly/2Q3Fe2f Morbidity and Mortality Weekly
Report, online May 10, 2019.
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |